Go to:
Logótipo
Você está em: Start » Programmes/Cycle of Studies » RFOC

Courses

Drug Repurposing for Oncology and COVID-19

Objectives

- Acquisition of theoretical skills and laboratory experimentation necessary for scientific research in oncological pharmacotherapy.

- Learning of theoretical-practical and practical skills to decide the best strategy for reusing drugs;

- Learning drug combination methodology;

- Studies of pharmacokinetic, pharmacodynamic and pharmacogenomic variability in oncology.

Professional Abilities

- Domain of the theoretical bases for understanding the concepts in the context of Oncological Pharmacotherapy;

- Execution of experimental technical work and interpretation of results in the areas of cell biology and therapeutic pharmacology;

- Application of the knowledge acquired in the conceptualization of a project to reuse drugs in oncology and COVID-19.

Information

Languague: Portuguese and partially in English


Number of participants:
 20 (max)/5 (min).


Target audience: 

Researchers, university students at the end of their degree, graduates and graduate students (master's and doctoral students) in the areas of Health.



Comments

To assist you in the registration process, please use the Aplication Online Guide:

 APPLICATION ONLINE HERE



To assist the registration, you can consult the 
Guide Support (2)

REGISTRATION ONLINE HERE

 


Contacts

Núcleo de Ensino Pós-Graduado
Educação Contínua - Cursos não conferentes de grau
Tel.: 220426975
e-mail: posgraduacao@med.up.pt

General information

Teacher Responsible: Nuno Vale
Acronym: RFOC
Type of course/cycle of study: Continuing Training Course
Start: 2020/2021
Duration: 216 Hour

Certificates

  • Drug Repurposing for Oncology and COVID-19 (8 ECTS credits)

Predominant Scientific Areas

Recommend this page Top
Copyright 1996-2026 © Faculdade de Medicina da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Last update: 2024-07-04 I  Page created on: 2026-05-03 at 06:10:06
Privacy Policy | Personal Data Protection Policy | Digital Image Capture and Dissemination Policy | Whistleblowing | Electronic Yellow Book